This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Neobiotics Ab. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2012
Title: Aftab Jasir: Innovator in Antimicrobial Agents
Introduction
Aftab Jasir is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of antimicrobial agents, focusing on innovative compounds that can be used in medical applications. With a total of 2 patents, his work is paving the way for advancements in treating microbial diseases.
Latest Patents
Aftab Jasir's latest patents include groundbreaking inventions such as peptide derivatives useful as antimicrobial agents and for treating wounds. One of his notable compounds has the general formula (I) R—NH—CH[(CH)—NH—C(NH)—NH]-CO—R-A-R. This compound is described as a pharmaceutical composition that can be used for manufacturing a medicament aimed at treating diseases, including microbial infections and the proliferation or stimulation of eukaryotic cells. Another significant invention involves antimicrobial compounds, which relate to compositions comprising a compound based on the general formula (I) R-Arg-R—NH—CH(R)—CH—NH—R (I) along with a carrier, diluent, or excipient.
Career Highlights
Aftab Jasir is currently associated with Neobiotics AB, where he continues to develop innovative solutions in the field of antimicrobial research. His work is characterized by a strong focus on practical applications that can significantly impact healthcare.
Collaborations
Throughout his career, Aftab has collaborated with esteemed colleagues such as Claes Schalén and Anders Grubb. These partnerships have fostered a collaborative environment that enhances the development of new technologies and solutions.
Conclusion
Aftab Jasir is a prominent figure in the field of antimicrobial research, with a focus on innovative compounds that hold promise for medical applications. His contributions are vital in the ongoing fight against microbial diseases, and his work continues to inspire advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile